Cargando…
Effect of C-Peptide on Diabetic Neuropathy in Patients with Type 1 Diabetes
Recent results indicate that proinsulin C-peptide, contrary to previous views, exerts important physiological effects and shows the characteristics of a bioactive peptide. Studies in type 1 diabetes, involving animal models as well as patients, demonstrate that C-peptide in replacement doses has the...
Autores principales: | Ekberg, Karin, Johansson, Bo-Lennart |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266809/ https://www.ncbi.nlm.nih.gov/pubmed/18350117 http://dx.doi.org/10.1155/2008/457912 |
Ejemplares similares
-
Type 1 Diabetic Neuropathy and C-peptide
por: Sima, Anders A. F., et al.
Publicado: (2004) -
C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients
por: Hach, Thomas, et al.
Publicado: (2008) -
The Association of Fasting C-peptide with Corneal Neuropathy in Patients with Type 2 Diabetes
por: Zuo, Anju, et al.
Publicado: (2020) -
Molecular and Cellular Effects of C-peptide—New Perspectives on an Old Peptide
por: Wahren, John, et al.
Publicado: (2004) -
HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)